Skip to content

The Combine Effect Of Sariva Ghan Vati And Nimba Patra Lepa In Yuvanpidika.

To Evaluate The Combine Effect Of The Sariva Ghan Vati And Nimba Patra Lepa In Yuvanpidika (Acne Vulgaris) An Open-Label Single Arm Clinical Trial. - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083262
Enrollment
50
Registered
2025-03-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified Health Condition 2: L989- Disorder of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Sponsors

Shree Swaminarayan Ayurvedic College,kalol
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age: 18 to 25 years. 2.Having classical signs & symptoms of Yauvanpidika like Paka, Srava,Kandu, Vedana, and Daha and also associated symptoms of Acne Vulgaris like Comedone, Papules, Pustules, Nodules, Cysts.

Exclusion criteria

Exclusion criteria: 1.Allergic / Hypersensitivity of any other drug will be excluded. 2.Pidika due to any systemic diseases known case of Prameha, Masurika. were also excluded from the present study. 3.Patients using Local applications containing Steroids and Narcotics. 4.Acne conglobate, Acne nodular, Herpes, and Nodular cystic acne are excluded. 5.K/C/O Cancer, AIDS, Psoriasis, TB that leads to fatal condition for patients.

Design outcomes

Primary

MeasureTime frame
1.Relife in the symptoms of yuvanpidika. 2.To evaluate combine efficacy of Sarivaghanvati and Nimbapatralepa in Acne vulgaris (Yuvanpidika).Timepoint: 30 days

Secondary

MeasureTime frame
1.To study the concept of Acne vulgaris (Yuvanpidika).Timepoint: 30 days

Countries

India

Contacts

Public ContactSahadev Ashok Patil

Shree Swaminarayan Ayurvedic College,Kalol,

vishal12solanki@gmail.com9558121886

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026